Identification of SHV-type and CTX-M-12 Extended-Spectrum β-Lactamases (ESBLs) in multiresistant Enterobacteriaceae from Colombian Caribbean hospitals

Journal of Chemotherapy

Volumn 22, Issue 3, 2010, Pages 160-164

  Espinal, P ^a   Garza Ramos, U ^b   Reyna, F ^b   Rojas Moreno, T ^b   Sanchez Perez, A ^b   Carrillo, B ^b   Martinez, P ^c   Mattar, S ^c   Silva Sanchez, Jesus ^b  

^a UNIVERSIDAD DEL SINÚ   (Colombia)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c UNIVERSIDAD DE CÓRDOBA   (Colombia)

Author keywords

CTX M 12; ESBL; Escherichia coli; Klebsiella pneumoniae; SHV 12; SHV 86

Indexed keywords

AMIKACIN; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 12; BETA LACTAMASE SHV; BETA LACTAMASE SHV 12; BETA LACTAMASE SHV 2A; BETA LACTAMASE SHV 5; BETA LACTAMASE SHV 86; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM IDENTIFICATION; COLOMBIA; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE AMPLIFICATION; GEOGRAPHIC DISTRIBUTION; HOSPITAL; ISOELECTRIC POINT; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS;

EID: 78650253639     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2010.22.3.160     Document Type: Article

References (23)

1. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14(4):933-51, table.
2. Paterson DL, Bonomo RA. Extended-spectrum beta-lactainases: a clinical update. Clin Microbiol Rev 2005; 18(4):657-686. (Pubitemid 41504510)
3. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48(1): 1-14. (Pubitemid 38040170)
4. Jeong SH, Bae IK, Lee JH, Sohn SG, Kang GH, Jeon GJ et al. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey. J Clin Microbiol 2004; 42(7):2902-2906. (Pubitemid 38938034)
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Document M100-S18. 2008. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Kaufmann ME. Pulse-field gel electrophoresis. Methods Mol Med. 1998; 15, 17-31.
7. Matthew M, Hedges RW. Analytical isoelectric focusing of R factor-determined beta-lactamases: correlation with plasmid compatibility. J Bacteriol 1976; 125(2):713-718.
8. Kieser T. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid. 1984;12, 19-36. (Pubitemid 14046088)
9. Miller J. Experiments in Moelcular Genetics. Cold Spring Harbor Laboratory Press. 2007.
10. Matthew M, Harris AM. Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. J Gen Microbiol 1976; 94(1):55-67.
11. Silva-Sanchez J, Aguilar-Zacarias C. beta-Lactamase bioassay: a simplified method to determine extended-spectrum beta-lactamases (ESBL) in enterobacteria. Arch Med Res 1997; 28(2):285-287.
12. Miranda G, Castro N, Leanos B, Valenzuela A, Garza-Ramos U, Rojas T et al. Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum beta-lactamase in a Mexican pediatric hospital. J Clin Microbiol 2004; 42(1):30-35. (Pubitemid 38082695)
13. Quinteros M, Radice M, Gardella N, Rodriguez MM, Costa N, Korbenfeld D et al. Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrob Agenls Chemother 2003; 47(9):2864-2867.
14. Arlet G, Philippon A. Construction by polymerase chain reaction and use of intragenic DNA probes for three main types of transferable beta-lactamases (TEM, SHV. CARB) [corrected]. FEMS Microbiol Lett 1991; 66(1):19-25.
15. Poirel L, Naas T, Nordmann P. Genetic support of extended-spectrum beta lactamases. Clin Microbiol Infect 2008; 14 Suppl 1:75-81.
16. Espinal PA, Mantilla JR, Saavedra CH, Leal AL, Alpuche C, Valenzuela EM. [Molecular epidemiology of nosocomial infection by extended-spectrum beta-lactamases-producing Klebsiella pneumoniae]. Biomedica 2004; 24(3):252-261.
17. Villegas MV, Correa A, Perez F, Zuluaga T, Radice M, Gutkind G et al. CTX-M-12 beta-lactamase in a Klebsiella pneumoniae clinical isolate in Colombia. Antimicrob Agents Chemother 2004; 48(2):629-631.
18. Poumaras S, Ikonomidis A, Kristo I, Tsakris A, Maniatis AN. CTX-M enzymes are the most common extended-spectrum beta-lactamases among Escherichia coli in a tertiary Greek hospital. J Antimicrob Chemother 2004; 54(2):574-575. (Pubitemid 39177493)
19. Chaves J, Ladona MG, Segura C, Coira A, Reig R, Ampurdanes C. SHV-1 beta-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45(10):2856-2861. (Pubitemid 32906682)
20. Nuesch Inderbinen MT, Kayser FH, Hachler H. Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob Agents Chemother 1997; 41(5):943-949. (Pubitemid 27194165)
21. Villegas MV, Kattan JN, Quinteros MG, Casellas JM. Prevalence of extended-spectrum beta-lactamases in South America. Clin Microbiol Infect 2008; 14 Suppl 1:154-158.
22. Eisner A, Fagan EJ, Feierl G, Kessler HH, Marth E, Livermore DM et al. Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum beta-lactamase in Austria. Antimicrob Agents Chemother 2006; 50(2):785-787.
23. Wu TL, Chia JH, Su LH, Chu C, Kuo AJ, Chiu CH. Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units of a medical center in Taiwan. Microb Drug Resist 2006; 12(3):203-209. (Pubitemid 44784045)